U.S. ARMY MEDICAL RESEARCH AND MATERIAL COMMAND Patent applications |
Patent application number | Title | Published |
20110189641 | Obstetrics Simulation and Training Method and System - An embodiment of the invention provides a method wherein a simulation system having a simulator, a processor, and at least one display is assembled. This includes assembling a birthing mannequin and a mobile cart having at least one touch-screen monitor, wherein the birthing mannequin includes a means for shaking to simulate a generalized seizure. The simulation system is provided along with documentation to a plurality of medical facilities within a system. Training on use of the simulator, different simulations, and criteria for grading performance on the simulations is also provided. The training includes team training for conducting the simulations using the simulation system. | 08-04-2011 |
20100119543 | USE OF SHIGELLA INVAPLEX TO TRANSPORT FUNCTIONAL PROTEINS AND TRANSCRIPTIONALLY ACTIVE NUCLEIC ACIDS ACROSS MAMMALIAN CELL MEMBRANES IN VITRO AND IN VIVO - The in vivo and in vitro use of Invaplex to transport materials, including functional proteins and biologically active nucleic acids, across eukaryotic cell membranes. The eukaryotic cells include a variety of cell types, e.g. insect, reptile, fish, mammal and tumor cells. The suitable materials for transport include biochemicals such as reporter molecules, antibiotics, biopharmaceuticals and carbohydrates including polysaccharides, lipopolysaccharides, polynucleotides, such as DNA and RNA, and glycoproteins and proteins including antigens, enzymes, antibodies, receptors and hormones. In addition, Invaplex enhances the immune response to DNA vaccines and also can function by itself as a vaccine against shigellosis. | 05-13-2010 |
20090305899 | Compositions and methods for determining immune status - The present invention provides compositions and methods for identifying molecules in samples that bind to molecules associated with pathogenic agents (e.g., infectious agents). In certain aspects, the invention may be used to identify individuals that have been exposed to one or more pathogenic agent or have generated antibodies in response to one or more pathogenic agent. In other aspects, the invention is directed to the identification of molecules of one or more pathogenic agent that may be used to generate immune responses in other individuals. | 12-10-2009 |